Humana recently reached a $90 million settlement with the United States to resolve allegations that Humana submitted ...
On October 8, 2024, PhRMA held a media briefing to address growing concerns over the Inflation Reduction Act (IRA) and its effects on the biopharmaceutical industry, Medicare Part D beneficiaries, and ...
Gentiva – formerly known as Kindred at Home – reached a $19.4 million settlement with the United States, resolving ...
The United States Department of Justice (DOJ) started a Corporate Whistleblower Awards Pilot Program to help uncover and ...
As healthcare costs soar, the Congressional Budget Office (CBO) has recently shed light on a hot political issue: the ...
Office of Prescription Drug Promotion (OPDP) recently sent an untitled letter to Mirati Therapeutics for claims made by the ...
Pioneering Discussions at IISLD 2024: Advancing Treatment for PBC and Alpha-1 Antitrypsin Deficiency
This year's International Symposium on Liver Diseases (IISLD) 2024, held in the San Diego Convention Center, includes two key ...
Office of Prescription Drug Promotion (OPDP) sent an Untitled Letter to Kaleo, Inc., regarding a social media post made by an influencer for its epinephrine injectable, Auvi-Q. The post was made by ...
In September of 2024, the U.S. Department of Health and Human Services (HHS) published its stamp of approval for telehealth accreditation programs. With federal backing, this may be an inflection ...
In a recent global compliance presentation at the Informaconnect, Aggregate Spend and HCP Engagement, Elon Shelf, Senior Compliance Advisor at MedPro, shared updates on transparency reporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback